Inventor
WONG MICHAEL K C
US23 patents
⚠️ This page may combine multiple inventors who share the name “WONG MICHAEL K C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
15 patentsUS7566718B2Jul 28, 2009
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP73 citations97
US7524842B2Apr 28, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP19 citations92
US7504424B2Mar 17, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP24 citations92
US7488745B2Feb 10, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP23 citations92
US7482370B2Jan 27, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP20 citations92
US7687527B2Mar 30, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP8 citations84
US7071213B2Jul 4, 2006
Cannabinoid receptor ligands
SCHERING CORP16 citations84
US7868005B2Jan 11, 2011
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP9 citations83
US7879838B2Feb 1, 2011
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
SCHERING CORP10 citations82
US7683085B2Mar 23, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP6 citations74
US7879890B2Feb 1, 2011
Compounds for the treatment of inflammatory disorders
SCHERING CORP6 citations73
US7772263B2Aug 10, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP7 citations73
US7868006B2Jan 11, 2011
Heterocyclic substituted piperazines with CXCR3 antagonist activity
SCHERING CORP3 citations62
US7683088B2Mar 23, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP1 citations62
US7645774B2Jan 12, 2010
Cannabinoid receptor ligands
SCHERING CORP0 citations52